STOCK TITAN

IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

IGM Biosciences (Nasdaq: IGMS) will have CEO Fred Schwarzer participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day on February 12, 2021, at 2:00 p.m. ET. The event will be held virtually, with a live webcast available on the company's website. A replay will be accessible for 90 days following the presentation. IGM Biosciences specializes in developing engineered IgM antibodies to enhance therapeutic applications.

Positive
  • None.
Negative
  • None.

MOUNTAIN VIEW, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day on February 12, 2021 at 2:00 p.m. ET. The conference will be held in a virtual meeting format.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact:

Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com


FAQ

What is the date and time of the IGM Biosciences event?

The IGM Biosciences event will take place on February 12, 2021, at 2:00 p.m. ET.

Who is participating in the IGM Biosciences fireside chat?

Fred Schwarzer, the CEO of IGM Biosciences, will participate in the fireside chat.

Where can I watch the IGM Biosciences webcast?

The webcast can be viewed on the 'Events and Presentations' page of IGM Biosciences' website.

How long will the IGM Biosciences webcast be available?

The replay of the IGM Biosciences webcast will be archived for 90 days after the presentation.

What is the focus of IGM Biosciences as a company?

IGM Biosciences focuses on creating and developing engineered IgM antibodies for therapeutic applications.

IGM Biosciences, Inc.

NASDAQ:IGMS

IGMS Rankings

IGMS Latest News

IGMS Stock Data

531.61M
21.80M
35.05%
63.99%
5.68%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MOUNTAIN VIEW